The pediatric clinical trial market is poised for significant growth, projected to expand at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2034. According to recent industry analysis, the market value is expected to surge from USD 17,918.1 million in 2024 to an impressive USD 31,661.0 million by 2034. This follows a robust growth period from 2019 to 2023, where the market expanded at a CAGR of 6.5%, reaching USD 16,831.0 million in 2023.
Pediatric clinical trials are essential for developing safe and effective treatments tailored for children, addressing a critical need in healthcare. This market growth is driven by increased research and development activities, rising investments in pediatric healthcare, and growing awareness about the importance of specialized clinical trials for children.
Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15017
The therapeutic area category in oncology placed second in terms of global sales share in 2021. Globally, cancer is the leading cause of mortality. By 2040, 291,000 more cases of cancer among children under the age of 19 are expected to be reported. The number of pediatric clinical trials is rising globally as a result of hospitals and other institutions concentrating on the development of therapeutic medications in response to the rising number of cases of juvenile cancer worldwide.
The worldwide market for pediatric clinical trials may be hampered for a number of reasons despite all of these growing factors. It is projected that the market for pediatric clinical trials would grow slowly due to the large number of studies that terminate for various reasons.
Pivotal Pediatric Clinical Trial Providers:
- Synteract
- ICON Plc.
- Syneos Health
- Medpace, Inc
- PPD Inc.
- Premier Research
- LabCorp Drug Development
- QPS Holding
- Pfizer Inc.
- The Emmes Company, LLC
- IQVIA Inc.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15017
Key Market Segmentation:
By Area:
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Respiratory Diseases
- Diabetes
- HIV
- Others
By Sponsor:
- Industry
- Government Organizations
- Non-Government Organizations
- Associations
- Others
By Phases:
- Phase 1
- Phase 2
- Phase 3
- Phase 4
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- MEA
In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15017
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
